Responses
Cervical cancer
2022-RA-721-ESGO Clinical outcomes of SBRT boost to the cervix as an alternative to intracavitary brachytherapy in locally advanced cervical cancer: Retrospective analysis from the West of Scotland
Compose a Response to This Article
Other responses
No responses have been published for this article.